Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
02/07/2006 | US6995133 invention describes reduced synthesis of IFN alpha 5 in livers of patients with hepatitis C in comparison to healthy livers; demonstrates importance of use of such interferon sub-types in fabricating compositions for treating viral hepatopathies |
02/07/2006 | US6995007 Antifungal bacterium ATCC PTA-4838 |
02/07/2006 | US6995004 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β 1,3-N-ACETYLGALACTOSAMINE-α-R / N-ACETYLGLUCOSAMINE-β 1,3,-N-ACETYLGALACTOSAMINE-α-R (GLCNAC TO GALNAC) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2/4GNT |
02/07/2006 | US6995003 Altering the consensus C-terminal targeting sequence of desacetoxycephalosporin C synthetase, a modified enzymes expressed from recombinant DNA in host cell Penicillium chrysogenum; improve cephalosporins production |
02/07/2006 | US6995002 Nucleotide sequences which code for the mdhA gene |
02/07/2006 | US6995000 Nucleotide sequences coding for the sigM gene |
02/07/2006 | US6994999 Isolated DNA molecule comprising the promoter sequence of a bovine myostatin gene |
02/07/2006 | US6994995 Specified sequences; expression vectors and host cells; share sequence similarity with mammalian synaptotagmins which have been implicated in membrane traffic and calcium dependent neuroexocytosis and are drug targets |
02/07/2006 | US6994994 Of the tumor necrosis factor receptor family; given amino acid sequence; use treating diseases and disorders ameliorated or cured by decreasing the levels of ligands of the original CD40R such as autoimmune diseases |
02/07/2006 | US6994993 Nucleotide sequences coding membrane protein for use inthe treatment of epilepsey, arrhythmia, and pain in humans |
02/07/2006 | US6994989 Fetal liver kinase 1 (flk-1), is a member of the type III subclass of receptor tyrosine kinase (RTK) family; specified amino acid and nucleotide sequences; expression vectors; expression by a host cell; modulators of angiogenesis |
02/07/2006 | US6994987 Process for producing tripeptides |
02/07/2006 | US6994985 use of the interaction of bacteriophage T4 AsiA protein and the C-terminal DNA binding domain of sigma factor (the SR4 domain) to screen for agents capable of binding and inhibiting sigma factor activity; screening for microbiocides for pathogens |
02/07/2006 | US6994978 Human osteoclast derived cathepsin |
02/07/2006 | US6994960 Detecting a mutation between a nucleic acid molecule to be tested and a reference nucleic acid molecule by base specific cleavage followed by Matrix-Assisted Laser Desorption/Ionization MS; does it require a gel electrophoresis step |
02/07/2006 | US6994861 Antiprotozoa agents; parasiticides; prevention abortion in mammals |
02/07/2006 | US6994860 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
02/07/2006 | US6994851 cytotoxic T-lymphocyte (CTL) response; comprises placing a physiologically-acceptable, antigen-containing composition in a reservoir having a pump for delivering the composition at a defined rate through a transmission line |
02/07/2006 | US6994850 Comprise yeast cells and swine manure; yeast cells have ability to fix atmospheric nitrogen, decompose phosphorus and potassium and complex carbon compounds, overproduce growth factors, overproduce ATP, suppress microorganisms |
02/07/2006 | US6994849 Yeast Metschnikowia fructicola NRRL Y-30752 for inhibiting deleterious microorganisms on plants |
02/07/2006 | US6994848 Lactobacillus paracasei strain GM-080 for treating allergy related diseases |
02/03/2006 | CA2851822A1 Improved liquid handling for filtration and preparative chromatography |
02/02/2006 | WO2006012366A2 Methods for making and using recombinant bacillus thuringiensis spores |
02/02/2006 | WO2006012326A1 Delta-8 desaturase and its use in making polyunsaturated fatty acids |
02/02/2006 | WO2006012325A1 Delta-8 desaturase and its use in making polyunsaturated fatty acids |
02/02/2006 | WO2006010930A2 Enzymes |
02/02/2006 | WO2004101753A3 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts |
02/02/2006 | WO2004083454A8 Wheel motion control input device for animation system |
02/02/2006 | WO2004005525A3 Microorganisms and processes for enhanced production of pantothenate |
02/02/2006 | WO2002094990A3 Receptors and membrane-associated proteins |
02/02/2006 | US20060026721 Plant cellulose synthases |
02/02/2006 | US20060026707 Isolated from Zea mays; transformed plant; can be used to repress the expression of a desired target gene in specific plant tissue or to prevent the repression of a particular desired target gene |
02/02/2006 | US20060025576 Multivalent antibodies and uses therefor |
02/02/2006 | US20060025575 Hybridoma cell line producing monoclonal antibodies to bind to, to detect and qualitatively and quantitatively measure the presence of epitopes of prion proteins; neurodegenerative diseases of the central nervous system |
02/02/2006 | US20060025360 Human cervical cancer protooncogene and protein encoded therein |
02/02/2006 | US20060024830 Growth characteristics of filamentous microorganisms |
02/02/2006 | US20060024811 Storing data encoded DNA in living organisms |
02/02/2006 | US20060024810 Method of atttaching nanotubes to bacteria and applications |
02/02/2006 | US20060024809 Ceramidase gene |
02/02/2006 | US20060024807 Kinase nucleic acids and polypeptides encoded by these nucleic acids; kinase inhibiitor design and indentifying inhibitors |
02/02/2006 | US20060024804 Isoforms isolated and purified from mammalian colostrum |
02/02/2006 | US20060024796 Transcriptional activator gene for genes involved in cobalamin biosynthesis |
02/02/2006 | US20060024795 Interferon-Like molecules and uses thereof |
02/02/2006 | US20060024792 G-protein coupled receptors |
02/02/2006 | US20060024789 Thermostable T1 lipase gene |
02/02/2006 | US20060024788 Inducible alphaviral gene expression system |
02/02/2006 | US20060024784 Phenol oxidizing enzymes |
02/02/2006 | US20060024782 Production of a monoclonal antibody in a heterokaryon filamentous fungus or in a filamentous fungal host cell |
02/02/2006 | US20060024773 Method for measuring intracellular gene transcription using blue luciferase from dinoflagellate |
02/02/2006 | US20060024760 Human brain carboxypeptidase B |
02/02/2006 | US20060024747 Comprises nucleotide sequences coding nitrillase and amidase for transformation and propagation of microorganism capable of catalyzing hydration of certain nitrites to corresponding amides and amides to corresponding carboxylic acids |
02/02/2006 | US20060024733 Storing data encoded DNA in living organisms |
02/02/2006 | US20060024712 Separation of nucleic acid |
02/02/2006 | US20060024701 Methods and reagents for the isolation of nucleic acids |
02/02/2006 | US20060024666 Humanized antibodies against the venezuelan equine encephalitis virus |
02/02/2006 | US20060024326 Biological compositions and methods for treatment of colorectal cancer |
02/02/2006 | US20060024325 Orally administered; activated and conditioned yeast cells; culturing yeast cells of Saccharomyces cerevisiae Hansen strain electromagnetic fields |
02/02/2006 | US20060024324 Glutamate-rich protein (GLURP) genetically coupled to plasmodium falciparum merozoite surface protein 3 (MSP3) for use as tool in preventing malarial infection; Antimalarial agents; parasiticides |
02/02/2006 | US20060024299 Human osteoclast derived cathepsin |
02/02/2006 | US20060024293 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
02/02/2006 | US20060024267 TNFr/OPG-like molecules and uses thereof |
02/02/2006 | US20060024233 Use of biomolecular targets in the treatment and visualization of brain tumors |
02/02/2006 | US20060021724 comprising a xylanolytic bacterial strain, providencia and a ligninolytic bacteria consisting of serratia, and pseudomonas; biologically pure cultures; environmentally friendly, safe and efficient |
02/02/2006 | CA2574698A1 Addition of transgenes into adenoviral vectors |
02/02/2006 | CA2568624A1 Delta-8 desaturase and its use in making polyunsaturated fatty acids |
02/01/2006 | EP1621635A2 Self-assembling recombinant HP16 papillomavirus capsid proteins |
02/01/2006 | EP1621628A2 Talaromyces emersonii beta-glucanases |
02/01/2006 | EP1621624A1 Genes for lysine biosynthetic system derived from thermophilic bacteria |
02/01/2006 | EP1621623A2 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitis |
02/01/2006 | EP1621621A1 Human 7tm protein receptors and polynucleotides encoding the same |
02/01/2006 | EP1621618A1 Cell concentration and lysate clearance using paramagnetic particles |
02/01/2006 | EP1621614A2 Herbicide target genes and methods |
02/01/2006 | EP1621609A1 PVA-decomposing bacteria and method for decomposing PVA |
02/01/2006 | EP1621608A1 Novel fungus capable of breaking urethane bond |
02/01/2006 | EP1621607A1 Basidiomycetes, basidiomycetes extract composition, and health foods and immunopotentiators |
02/01/2006 | EP1621556A1 Method of producing target protein, fused protein and gene thereof, partial sequence protein of intein and gene thereof, expression vector and transformant |
02/01/2006 | EP1621554A1 Immunoglobulins devoid of light chains |
02/01/2006 | EP1621548A2 Polypeptides, CDNAs encoding the same and utilization thereof |
02/01/2006 | EP1621218A1 Auologous bone graft material |
02/01/2006 | EP1621082A2 Process and an enzyme for use in such a process |
02/01/2006 | EP1620723A1 Method for identifying modulators of clk-1 and ubif activity |
02/01/2006 | EP1620552A2 Use of glycodendrimer reagents for inhibiting adhesion by microorganisms |
02/01/2006 | EP1620543A2 Production of polyunsaturated fatty acids in oleaginous yeasts |
02/01/2006 | EP1620542A2 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts |
02/01/2006 | EP1620454A2 Genes encoding carotenoid compounds |
02/01/2006 | EP1620057A2 Modified heat-generating cosmetic compositions |
02/01/2006 | EP1223953B1 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
02/01/2006 | EP1200479B1 Multiple cytokine-antibody complexes |
02/01/2006 | EP1141702B1 Method for measuring nitrification rates in biochemical processes |
02/01/2006 | EP1100928B1 Bifunctional enzymes for biopolymer production |
02/01/2006 | EP0996738B1 Recombinant vector containing infectious, viral genome sequences greater than 100 kb, method for producing same and use for the mutagenesis of the viral sequences |
02/01/2006 | EP0934418B1 Microbial preparation of substances from aromatic metabolism/i |
02/01/2006 | EP0922056B1 New fibrinogen binding protein originating from coagulase-negative staphylococcus |
02/01/2006 | EP0894126B1 Alkaline protease deficient filamentous fungi |
02/01/2006 | CN1729290A Gene expressed specifically in dopamine-producing neuron precursor cells after termination of division |
02/01/2006 | CN1729288A Novel nitrile hydratase |
02/01/2006 | CN1729286A Pseudomonas sp. FK916 producing decomposition enzyme of organic matter and method for decomposition of organic waste using the same |
02/01/2006 | CN1727481A Gene for anti mosaic virus of tomato, and separation method |
02/01/2006 | CN1727470A Method for constructing engineering bacterium of recombined compounding interferon |